Alterations in red blood cell parameters associated with the use of hormonal contraceptives
Main Article Content
Abstract
Introduction. Hormonal contraceptives are widely used worldwide due to their effectiveness in preventing unwanted pregnancies. In addition to their contraceptive function, these drugs offer multiple non-contraceptive benefits, such as regulating the menstrual cycle, reducing pain associated with dysmenorrhea, decreasing excessive menstrual bleeding, and treating acne and polycystic ovary syndrome. However, numerous studies have shown that their use can induce changes in hematological parameters, particularly in the red cell series and platelets. These modifications vary depending on the type of contraceptive, the route of administration, and the duration of treatment. Objective. To analyze the alterations in red blood cell parameters and platelet count associated with the use of diverse types of hormonal contraceptives in women. Methodology. An information search was conducted in various databases, including PubMed, Scopus, BVS, Cochrane Library, Elsevier, and books, considering studies published in both English and Spanish. Results. Combined oral contraceptives and quarterly progestogen-only injections are associated with clear increases in red blood cell count, hemoglobin, hematocrit, and platelet count. In contrast, transdermal patches, the vaginal ring, and the hormonal IUD maintain stable erythrocyte indices and platelet counts. Subdermal implants, on the other hand, do not usually alter these parameters initially, but prolonged use can cause irregular uterine bleeding, which over time leads to a decrease in red blood cell count, hematocrit, MCV, and MCH due to the progressive depletion of iron stores. Conclusion. The hematological effects of hormonal contraceptives vary according to their type and duration of use. While combined oral contraceptives and injectable progestogens promote an increase in erythrocyte and platelet parameters due to reduced menstrual bleeding and possible erythropoietic stimulation, chronic use of subdermal implants may induce changes consistent with iron deficiency. General field of study: Health Sciences Specific field of study: Clinical Laboratory Type of study: Narrative literature review.
Downloads
Article Details
References
2. Gedfie S, Getawa S, Kassahun W, Gashaye KT, Melku M. Hematological parameters of reproductive-age women using hormonal contraceptives at University of Gondar Comprehensive Specialized Referral Hospital, Northwest Ethiopia: A comparative cross-sectional study. PLoS One [Internet]. 2022 [cited 2025 April 20]; 17(11): e0277254. Available from: http://dx.doi.org/10.1371/journal.pone.0277254
3. Heikinheimo O, Toffol E, Partonen T, But A, Latvala A, Haukka J. Systemic hormonal contraception and risk of venous thromboembolism. Acta Obstetricia et Gynecologica Scandinavica [Internet]. 2022 [cited 2025 April 20]; 101(8):846–855. Available from: http://dx.doi.org/10.1111/aogs.14384
4. Sandin L, von Below A, Waller M, Björkelund C, Blomstrand A, Runevad R, et al. Trends in haemoglobin levels from 1968 to 2017 and association with hormonal contraceptives: observations from the population study of women in Gothenburg, Sweden. Scandinavian Journal of Primary Health Care [Internet]. 2023 [cited 2025 April 20];41(3):214–223. Available from: http://dx.doi.org/10.1080/02813432.2023.2222767
5. Bizjak I, Envall N, Emtell Iwarsson K, Kopp Kallner H, Gemzell-Danielsson K. Contraceptive uptake and compliance after structured contraceptive counseling - secondary outcomes of the LOWE trial. Acta Obstetricia et Gynecologica Scandinavica [Internet]. 2024 [cited 2025 April 20]; 103(5):873–883. Available from: http://dx.doi.org/10.1111/aogs.14792
6. De Aquinp Moreira IF, Bianchini MP, Campos Moreira GR, Almeida AM, Rezende BA. Sexual function and metabolic/hormonal changes in women using long-term hormonal and non-hormonal contraceptives: a pilot study. BMC Women's Health [Internet]. 2020 [cited 2025 April 20];20(240). Available from: http://dx.doi.org/10.1186/s12905-020-01107-1
7. Katabi L, Stevens E, Ascha M, Arora K. Characteristics of patients requiring surgical removal of subdermal contraceptive implants: A case-control study. Open Access Journal of Contraception [Internet]. 2022 [cited 2025 April 20]; 2022(13):111–119. Available from: http://dx.doi.org/10.2147/OAJC.S368250
8. Saloranta TH, Gyllenberg FK, But A, Gissler M, Heikinheimo O, Laine MK. Use of reproductive health services among women using long- or short-acting contraceptive methods – a register-based cohort study from Finland. BMC Public Health [Internet]. 2022 [cited 2025 April 20];22(1185). Available from: http://dx.doi.org/10.1186/s12889-022-13581-3
9. Li L, Yang X, Tran D, Seo SK, Lu Y. Combined oral contraceptives as victims of drug interactions. Drug Metabolism and Disposition [Internet]. 2023 [cited 2025 April 20];51(6):718–732. Available from: http://dx.doi.org/10.1124/dmd.122.000854
10. Ulukapi HB, Simsek E. Comparison of combined oral contraceptives and a transdermal estrogen patch with oral progesterone: Treatment of abnormal uterine bleeding in adolescents. Cureus [Internet]. 2024 [cited 2025 April 20]; 16(10): e72218. Available from: http://dx.doi.org/10.7759/cureus.72218
11. Saha T, Bharadwaj MK, Vardhan S. A randomized controlled trial to study the efficacy of intravaginal hormonal ring for control of heavy menstrual bleeding as compared to combined oral contraceptive pills. International Journal of Reproduction, Contraception, Obstetrics and Gynecology [Internet]. 2020 [cited 2025 April 20];9(3):1205-1212. Available from: http://dx.doi.org/10.18203/2320-1770.ijrcog20200901
12. Essis EM-L, Yeo KJ, Amalaman DM, Konan LL, Bamba I, Coulibaly KSA, et al. Libido-sexual disorders and abandonment of injectable contraceptives among users of the Ivorian Association for Family Well-Being in Korhogo, Côte d’Ivoire. Frontiers in Global Women's Health [Internet]. 2023 [cited 2025 April 20]; 4:1026253. Disponible en: http://dx.doi.org/10.3389/fgwh.2023.1026253
13. Tekle E, Gelaw Y, Asrie F. Hematological profile changes among oral contraceptive users. Journal of Blood Medicine [Internet]. 2022 [cited 2025 April 20];13: 525–536. Available from: http://dx.doi.org/10.2147/JBM.S379841
14. Okoroiwu IL, Obeagu EI, Egwim V. Assessment of white blood cell count, and platelet count in women on hormonal contraceptives in Owerri, Imo State, Nigeria. Journal of Research in Medical and Dental Sciences [Internet]. 2021 [cited 2025 April 20];9(12):498–501. Available from: https://www.jrmds.in/articles/assessment-of-white-blood-cell-count-and-platelet-count-in-women-on-hormonal-contraceptives-in-owerri-imo-state-nigeria-87669.html#ai
15. Karra M, Canning D. Hormonal contraception and hemoglobin levels in urban Malawi: A longitudinal analysis. Research Square [Internet]. 2023 [cited 2025 April 20]. Available from: http://dx.doi.org/10.21203/rs.3.rs-3490479/v1
16. Al-Jassani MJ, Hasan SY, Adnan A, Allela OQB, Alsaraf KM, Kadhim AJ, et al. The effect of contraceptive pills on the physiological parameters of blood and hormones on women in Al-qurna, Iraq. International Journal of Pharmaceutical Quality Assurance [Internet]. 2023 [cited 2025 April 20];14(4):853–855. Available from: http://dx.doi.org/10.25258/ijpqa.14.4.04
17. Beltrán DA, Crespo AB, Valle SG. Effect of four hormonal contraceptives on platelet count and coagulation parameters under real conditions of use after 6 months of treatment. Food Science & Nutrition [Internet]. 2020 [cited 2025 April 20];6. Available from: http://dx.doi.org/10.24966/fsn-1076/100066
18. Onuigwe FU, Yahaya K, Uchechukwu NJ, Buhari HA. Some haematological parameters in women on different types of contraceptives attending specialist hospital, Sokoto, Sokoto State, Nigeria. African Journal of Laboratory Hematology and Transfusion Science [Internet]. 2025 [cited 2025 May 28]; 3(2): 93-106. Available from: https://www.ajlhtsonline.org/doi-org-10-59708-ajlhts-v3i2-2407/
19. Egbunah MO, Eze EM, Ebirien-Agana BS, Jeremiah ZA. Haematological profiles of women on some contraceptives in selected family planning clinics in Kaduna State, Nigeria. Journal of Medical Science and Clinical Research [Internet]. 2018 [cited 2025 May 28];6(12): 73-84. Available from: http://dx.doi.org/10.18535/jmscr/v6i12.12
20. Frances NO, Ezigbo DED, Ezinwa CN. The effects of different forms of contraceptives on the coagulation profile: A prospective case-control study. International Journal of Contemporary Pathology [Internet]. 2024 [cited 2025 May 28];10(2). Available from: http://dx.doi.org/10.37506/5evcbf35
21. Okafor IM, Etura JE, Ogar AO. Some haematological parameters of female students on oral contraceptives: A case study in University of Calabar, Calabar, Cross River State, Nigeria. Sokoto Journal of Medical Laboratory Science [Internet]. 2023 [cited 2025 May 28];8(4):91–99. Available from: https://sokjmls.com.ng/index.php/SJMLS/article/view/409/377
22. Balogun OR, Adeniran AS, Adewole AA. Haematological and biochemical effects of etonogestrel subdermal implant (Implanon) in Ilorin Nigeria. International Journal of Health Sciences (Qassim) [Internet]. 2016 [cited 2025 May 28]; 10(4):499–506. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5085344/
23. Jamil S, Khan RA, Dilshad HD, Fatima S. Haematologic variations associated with the long-term use of contraceptives in young females. American Journal of Phytomedicine and Clinical Therapeutics [Internet]. 2014 [cited 2025 May 28]; 2(5):580–586. Available from: https://www.researchgate.net/publication/274780484_Hematologic_variations_associated_with_the_long_term_use_of_contraceptives_in_young_females
24. Moraleda Jiménez JM, Alegre Amor A, Álvarez Larrán A, Anguita Velasco J, Arranz Sáez R, Arrizabalaga Amuchastegui B, et al. Pregrado de hematología [Internet]. Sociedad Española de Hematología y Hematoterapia; 2017 [citado 28 mayo 2025]. Disponible en: https://www.sehh.es/images/stories/recursos/2017/10/Libro-HEMATOLOGIA-Pregrado.pdf